In this issue of Surgical Pathology Clinics, guest editor Dr. Alain Borczuk brings his considerable expertise to the topic of New Frontiers in Thoracic Pathology. Top experts provide new insights into emerging technology that will affect thoracic pathology in both neoplastic and non-neoplastic disease. This issue covers updates in the utilization of molecular testing in surgical pathology of lung cancer and mesothelioma, highlights uncommon tumors in the differential of common tumors, and shares new approaches to non-neoplastic disease, including new clinicopathologic entities.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. ix 7. Preface - p. xi 8. Smoking-Related Interstitial Lung Disease: Historical Perspective and Advances in the Twenty-first Century - p. 159 9. Granulomatous Lung Diseases: A Practical Approach and Review of Common Entities - p. 173 10. Update on Silicosis - p. 193 11. Pathology of COVID-19 Lung Disease - p. 203 12. Interstitial Lung Abnormalities - p. 215 13. Evolving Diagnostic Approach of Pulmonary Salivary Gland-type Tumors - p. 227 14. Sarcoma of the Lung and Mediastinum - p. 243 15. Nonmesothelial Spindle Cell Tumors of Pleura and Pericardium - p. 257 16. Invasion and Grading of Pulmonary Non-Mucinous Adenocarcinoma - p. 271 17. Pathologic Response Evaluation in Neoadjuvant-Treated Lung Cancer - p. 287 18. Microsatellite Instability, Mismatch Repair, and Tumor Mutation Burden in Lung Cancer - p. 295 19. Molecular Testing in Lung Cancer: Recommendations and Update - p. 307 20. Applications of Artificial Intelligence in Lung Pathology - p. 321
In this issue of Surgical Pathology Clinics, guest editor Dr. Alain Borczuk brings his considerable expertise to the topic of New Frontiers in Thoracic Pathology. Top experts provide new insights into emerging technology that will affect thoracic pathology in both neoplastic and non-neoplastic disease. This issue covers updates in the utilization of molecular testing in surgical pathology of lung cancer and mesothelioma, highlights uncommon tumors in the differential of common tumors, and shares new approaches to non-neoplastic disease, including new clinicopathologic entities.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. ix 7. Preface - p. xi 8. Smoking-Related Interstitial Lung Disease: Historical Perspective and Advances in the Twenty-first Century - p. 159 9. Granulomatous Lung Diseases: A Practical Approach and Review of Common Entities - p. 173 10. Update on Silicosis - p. 193 11. Pathology of COVID-19 Lung Disease - p. 203 12. Interstitial Lung Abnormalities - p. 215 13. Evolving Diagnostic Approach of Pulmonary Salivary Gland-type Tumors - p. 227 14. Sarcoma of the Lung and Mediastinum - p. 243 15. Nonmesothelial Spindle Cell Tumors of Pleura and Pericardium - p. 257 16. Invasion and Grading of Pulmonary Non-Mucinous Adenocarcinoma - p. 271 17. Pathologic Response Evaluation in Neoadjuvant-Treated Lung Cancer - p. 287 18. Microsatellite Instability, Mismatch Repair, and Tumor Mutation Burden in Lung Cancer - p. 295 19. Molecular Testing in Lung Cancer: Recommendations and Update - p. 307 20. Applications of Artificial Intelligence in Lung Pathology - p. 321
